Ayala Pharmaceuticals Total Non Current Liabilities 2011-2026 | AYLA

Annual Total Non Current Liabilities Ayala Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	553 K	299 K	46.2 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
46.2 M	299 K	15.7 M

Quarterly Total Non Current Liabilities Ayala Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	396 K	414 K	472 K	497 K	493 K	502 K	505 K	553 K	553 K	553 K	553 K	299 K	299 K	299 K	299 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
553 K	299 K	446 K

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	99.5 M	$ 15.94	-3.66 %	$ 3.8 B	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	326 M	$ 3.51	-3.31 %	$ 1.05 B	Canada
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aptorum Group Limited APM	2.21 M	$ 0.84	1.57 %	$ 4.58 M	China
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.16	1.51 %	$ 2.54 B	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	182 M	$ 75.6	-1.22 %	$ 1.46 B	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.49	-8.59 %	$ 380 M	Britain
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 162.3	-1.08 %	$ 8.07 B	USA
BridgeBio Pharma BBIO	97.6 M	$ 65.02	-2.29 %	$ 12.5 B	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.77	-1.42 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	635 M	$ 60.51	0.13 %	$ 11.6 B	USA
Equillium EQ	8.33 M	$ 1.75	-	$ 60.8 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.21	-6.52 %	$ 3.75 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	264 M	$ 3.01	-5.94 %	$ 1.08 M	USA
Capricor Therapeutics CAPR	4.86 M	$ 25.27	-0.9 %	$ 677 M	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 34.25	-4.03 %	$ 3.56 B	USA